Diagnostyka

Diagnostyka FCF Margin

The Free Cash Flow Margin of Diagnostyka (DIA.WA) as of Oct 27, 2026 is 14.40 %. In the previous year, Free Cash Flow Margin was 14.50 % — a change of -0.71% (lower).

FCF Margin

14.40 %

YoY

-0.71%

Last updated:

Free Cash Flow Margin of Diagnostyka is 2025 14.40 % . Free Cash Flow Margin of Diagnostyka was 2024 14.50 % . It decreases by -0.71% lower compared to the previous year.

The Diagnostyka FCF Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Margin
Date
FCF Margin
Jan 1, 2021
32.94 PLN
Jan 1, 2022
13.55 PLN
Jan 1, 2023
16.04 PLN
Jan 1, 2024
14.50 PLN
Jan 1, 2025
14.40 PLN
The Diagnostyka FCF Margin history
YEARFCF MarginYoY
14.40 %-0.71%
14.50 %-9.60%
16.04 %+18.36%
13.55 %-58.86%
32.94 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Diagnostyka Stock analysis

What does Diagnostyka do? Diagnostyka SA generates revenue through its network of 180 laboratories and 1,100 Sampling Labs across Poland, offering over 3,000 test types including hematology, infection diagnostics, allergology, and hormonal diagnostics. The company provides both routine and specialist laboratory services, with tests available with or without a physician's referral, catering to individual patients and healthcare providers. Its specialization in molecular biology, autoimmune diagnostics, and blood collection drives demand from private individuals seeking direct access to medical analysis without a doctor's prescription. The firm's revenue model relies on a comprehensive service chain from biological material collection and transportation to final analysis results, serving a broad customer base including patients, clinics, and hospitals. With a focus on accessible diagnostics, Diagnostyka SA expands its market reach through its extensive lab network, enabling widespread availability of medical testing services throughout Poland. The company's ability to deliver specialized tests like molecular biology and autoimmune diagnostics differentiates its offerings in the healthcare sector. Diagnostyka is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Diagnostyka stock

Free Cash Flow Margin of Diagnostyka is 14.40 % in 2025.

Free Cash Flow Margin of Diagnostyka changed from 14.50 % to 14.40 %, representing a -0.71% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow Margin Diagnostyka since 2006 – with annual values, charts, and detailed analysis.

FCF Margin measures the percentage of revenue converted to free cash flow. It indicates how efficiently a company generates cash from its operations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow Margin's Diagnostyka with sector peers and the industry average to assess whether it is attractive.

To evaluate Free Cash Flow Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Diagnostyka

All Key Metrics — Diagnostyka